Macular pigment optical density is related to blood glutathione levels in healthy individuals

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 9, 2011, Pages 5029-5033

  Qin, Lu ^a,b   Bartlett, Hannah ^a,b   Griffiths, Helen R ^a,b   Eperjesi, Frank ^a,b   Armstrong, Richard A ^a,b   Gherghel, Doina ^a,b  

^a Ophthalmic Research Group   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUTATHIONE; GLUTATHIONE DISULFIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ANTIOXIDANT; BIOLOGICAL MARKER; XANTHOPHYLL; ZEAXANTHIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; CRITICAL FLICKER FUSION; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE; HUMAN; MACULAR PIGMENT OPTICAL DENSITY; MALE; NORMAL HUMAN; PHOTOMETRY; PRIORITY JOURNAL; QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE; VISUAL SYSTEM PARAMETERS; AGED; BLOOD; CYTOLOGY; DENSITOMETRY; METABOLISM; METHODOLOGY; MIDDLE AGED; OXIDATIVE STRESS; PHYSIOLOGY; RETINA MACULA LUTEA;

ADULT; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DENSITOMETRY; FEMALE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; LUTEIN; MACULA LUTEA; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHOTOMETRY; TRIGLYCERIDES; XANTHOPHYLLS; YOUNG ADULT;

EID: 80054786622     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7240     Document Type: Article

References (50)

1. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-134.
2. Cai J, Nelson KC, Wu M, Sternberg Jr P, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19: 205-221.
3. Khandhadia S, Lotery A. Oxidation and age-related macular degeneration: insights from molecular biology. Expert Rev Mol Med. 2010;12:e34.
4. Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vision Res. 1985;25:1531-1535.
5. Khachik F, de Moura FF, Zhao DY, Aebischer CP, Bernstein PS. Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest Ophthalmol Vis Sci. 2002;43:3383-3392.
6. Krinsky NI. Possible biologic mechanisms for a protective role of xanthophylls. J Nutr. 2002;132:540S-542S.
7. Hammond Jr BR, Wooten BR, Snodderly DM. Preservation of visual sensitivity of older subjects: association with macular pigment density. Invest Ophthalmol Vis Sci. 1998;39:397-406.
8. Reading VM, Weale RA. Macular pigment and chromatic aberration. J Opt Soc Am. 1974;64:231-234.
9. Pease PL, Adams AJ, Nuccio E. Optical density of human macular pigment. Vision Res. 1987;27:705-710.
10. Rapp LM, Maple SS, Choi JH. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest Ophthalmol Vis Sci. 2000;41:1200-1209.
11. Krinsky NI. Carotenoid protection against oxidation. Pure Appl Chem. 1979;51:649-660.
12. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys. 1989;274:532-538.
13. Lim BP, Nagao A, Terao J, Tanaka K, Suzuki T, Takama K. Antioxidant activity of xanthophylls on peroxyl radical-mediated phospholipid peroxidation. Biochim Biophys Acta. 1992;1126: 178-184.
14. Sundelin SP, Nilsson SE. Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants. Free Radic Biol Med. 2001;31:217-225.
15. Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology. 2001;108:705-710.
16. Zaliuniene D, Jasinskas V, Jurkevicius R, Gustiene O, Zaliunas R. Endothelial function, intima-media thickness, and ankle-brachial index in patients with cataract and age-related macular degeneration. Eur J Ophthalmol. 2008;18:384-391.
17. Wong TY, Klein R, Sun C, et al. Age-related macular degeneration and risk for stroke. Ann Intern Med. 2006;145:98-106.
18. Wong TY, Tikellis G, Sun C, Klein R, Couper DJ, Sharrett AR. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Ophthalmology. 2007;114:86-91.
19. Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol. 2000;118:351-358.
20. Samiec PS, Drews-Botsch C, Flagg EW, et al. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med. 1998;24:699-704.
21. Evereklioglu C, Er H, Doganay S, et al. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc Ophthalmol. 2003;106:129-136.
22. Wenzel AJ, Sheehan JP, Burke JD, Lefsrud MG, Curran-Celentano J. Dietary intake and serum concentrations of lutein and zeaxanthin, but not macular pigment optical density, are related in spouses. Nutr Res. 2007;27:462-469.
23. Bhosale P, Zhao da Y, Bernstein PS. HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era. Invest Ophthalmol Vis Sci. 2007;48:543-549.
24. Upritchard JE, Schuurman CR, Wiersma A, et al. Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults. Am J Clin Nutr. 2003;78:985-992.
25. Ahsan H, Ali A, Ali R. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol. 2003;131:398-404.
26. Videla LA, Guerri C. Glutathione and alcohol. In: Vina J, ed. Glutathione: Metabolism and Physiological Functions. Boca Raton, FL: CRC Press; 1990:57-67.
27. Beutler E, Gelbart T. Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med. 1985;105:581-584.
28. Beard KM, Shangari N, Wu B, O'Brien PJ. Metabolism, not autoxidation, plays a role in alpha-oxoaldehyde-and reducing sugarinduced erythrocyte GSH depletion: relevance for diabetes mellitus. Mol Cell Biochem. 2003;252:331-338.
29. Jones DP, Coates RJ, Flagg EW, et al. Glutathione in foods listed in the National Cancer Institute's Health Habits and History Food Frequency Questionnaire. Nutr Cancer. 1992;17:57-75.
30. Anderson ME. Glutathione. In: Punchard NA, Kelly FJ, eds. Free Radicals: A Practical Approach. Oxford, UK: Oxford University Press; 1996:213-226.
31. Anderson ME, Meister A. Dynamic state of glutathione in blood plasma. J Biol Chem. 1980;255:9530-9533.
32. Jones DP, Carlson JL, Samiec PS, et al. Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin Chim Acta. 1998;275:175-184.
33. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 1980;106:207-212.
34. Gherghel D, Griffiths HR, Hilton EJ, Cunliffe IA, Hosking SL. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2005; 46:877-883.
35. van der Veen RL, Berendschot TT, Hendrikse F, Carden D, Makridaki M, Murray IJ. A new desktop instrument for measuring macular pigment optical density based on a novel technique for setting flicker thresholds. Ophthalmic Physiol Opt. 2009;29:127-137.
36. Howells O, Eperjesi F, Bartlett H. Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol. 2011;249:315-347.
37. Bartlett H, Stainer L, Singh S, Eperjesi F, Howells O. Clinical evaluation of the MPS9000 Macular Pigment Screener. Br J Ophthalmol. 2010;94:753-756.
38. Liang FQ, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res. 2003;76:397-403.
39. Davies NP, Morland AB. Macular pigments: their characteristics and putative role. Prog Retin Eye Res. 2004;23:533-559.
40. Bartlett H, Howells O, Eperjesi F. The role of macular pigment assessment in clinical practice: a review. Clin Exp Optom. 2010; 93:300-308.
41. Sternberg Jr P, Davidson PC, Jones DP, Hagen TM, Reed RL, Drews-Botsch C. Protection of retinal pigment epithelium from oxidative injury by glutathione and precursors. Invest Ophthalmol Vis Sci. 1993;34:3661-3668.
42. Yi C, Pan X, Yan H, Guo M, Pierpaoli W. Effects of melatonin in age-related macular degeneration. Ann N Y Acad Sci. 2005;1057: 384-392.
43. Reiter RJ, Tan DX, Paredes SD, Fuentes-Broto L. Beneficial effects of melatonin in cardiovascular disease. Ann Med. 2010;42:276-285.
44. Bendich A. Antioxidant micronutrients and immune responses. Ann N Y Acad Sci. 1990;587:168-180.
45. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol. 2003;66:1499-1503.
46. Charman WN. Age, lens transmittance, and the possible effects of light on melatonin suppression. Ophthalmic Physiol Opt. 2003; 23:181-187.
47. Skene DJ, Arendt J. Human circadian rhythms: physiological and therapeutic relevance of light and melatonin. Ann Clin Biochem. 2006;43:344-353.
48. Turner PL, Mainster MA. Circadian photoreception: ageing and the eye's important role in systemic health. Br J Ophthalmol. 2008;92:1439-1444.
49. Flagg EW, Coates RJ, Jones DP, et al. Plasma total glutathione in humans and its association with demographic and health-related factors. Br J Nutr. 1993;70:797-808.
50. Michelet F, Gueguen R, Leroy P, Wellman M, Nicolas A, Siest G. Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits. Clin Chem. 1995;41:1509-1517.